$3.39
-0.01[-0.29%]
At close: Apr 17
$3.39
0[0.00%]
After Hours: 6:53PM EDT
Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | GALT | Q1 | -$0.19 | -$0.16 | — | — | $0.00 | — | — | — | Get Alert |
03/29/2024 | AM | GALT | Q4 | -$0.18 | -$0.16 | -$0.16 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
11/13/2023 | AM | GALT | Q3 | -$0.14 | -$0.16 | -$0.24 | -50.00% | $0.00 | — | $0.00 | — | Get Alert |
08/14/2023 | AM | GALT | Q2 | -$0.16 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
05/15/2023 | AM | GALT | Q1 | -$0.17 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | Get Alert |
03/30/2023 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | GALT | Q3 | -$0.14 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | Get Alert |
08/15/2022 | AM | GALT | Q2 | -$0.15 | -$0.21 | -$0.16 | 23.81% | $0.00 | — | $0.00 | — | Get Alert |
05/16/2022 | AM | GALT | Q1 | -$0.11 | -$0.14 | -$0.17 | -21.43% | $0.00 | — | $0.00 | — | Get Alert |
03/31/2022 | AM | GALT | Q4 | -$0.13 | -$0.19 | -$0.12 | 36.84% | $0.00 | — | $0.00 | — | Get Alert |
11/15/2021 | AM | GALT | Q3 | -$0.10 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
08/16/2021 | AM | GALT | Q2 | -$0.11 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
05/17/2021 | AM | GALT | Q1 | -$0.06 | -$0.17 | -$0.11 | 35.29% | $0.00 | — | $0.00 | — | Get Alert |
03/31/2021 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | Get Alert |
11/09/2020 | AM | GALT | Q3 | -$0.05 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2020 | AM | GALT | Q2 | -$0.06 | -$0.09 | -$0.11 | -22.22% | $0.00 | — | $0.00 | — | Get Alert |
05/11/2020 | AM | GALT | Q1 | -$0.20 | -$0.09 | -$0.06 | 33.33% | $0.00 | — | $0.00 | — | Get Alert |
03/16/2020 | AM | GALT | Q4 | -$0.08 | — | -$0.12 | — | $0.00 | — | $0.00 | — | Get Alert |
11/12/2019 | AM | GALT | Q3 | -$0.07 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
Galectin Therapeutics (GALT) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 29, 2024 for Q4.
The Actual EPS was $-0.16, which hit the estimate of $-0.16.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.